Panel Approves New Cancer Drug, Paving the Way for First FDA-Approved Gene Therapy
Pharma giant Novartis's new cancer drug tisagenlecleucel passed a critical test by winning the support of a federal advisory panel - setting it up for final FDA approval in September.…